A case of insufficient evidence equipoise: The NICE guidance on antibiotic prophylaxis for the prevention of infective endocarditis

Journal of Medical Ethics

Volumn 36, Issue 9, 2010, Pages 567-570

  Mohindra, R K ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; ECONOMICS; ENDOCARDITIS; EQUIPOISE; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; RISK FACTOR; UNITED KINGDOM;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; ENDOCARDITIS; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; THERAPEUTIC EQUIPOISE;

EID: 77958108068     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/jme.2010.036848     Document Type: Article

References (42)

1. Shaw D, Conway DI. Pascal's Wager, infective endocarditis and the "no-lose" philosophy in medicine. Heart 2010;96:15-18.
2. Galbraith S. The 'no lose' philosophy in medicine. J Med Ethics 1978;4:61-3.
3. National Institute for Health and Clinical Excellence. Clinical Guideline 64: prophylaxis against infective endocarditis. http://www.nice.org.uk/nicemedia/pdf/CG64NICEguidance.pdf p66, p12, p11 (accessed 12 Feb 2010).
4. Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ 2008;336:770-1.
5. Weaver WD, Nishimura RA, Warnes CA. President's page: antimicrobial prophylaxis to prevent infective endocarditis: why did the recommendations change? J Am Coll Cardiol 2008;52:495-7.
6. Rawlins MD. The decade of NICE. Lancet 2009;374:351-2.
7. Rawlins MD. The failings of NICE. Reply from chairman of NICE. BMJ 2001;322:489.
8. Prendergast BD, Harrison JL, Naber CK. Commentary on endocarditis prophylaxis: a quaint custom or medical necessity? Heart 2008;94:931-4.
9. Oliver R, Roberts GJ, Hooper L, et al. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev 2008(4):CD003813.
10. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92:879-85.
11. Ashrafian H, Bogle RG. Antimicrobial prophylaxis for endocarditis: emotion or science? Heart 2007;93:5-6.
12. Duval X, Leport C, Danchin N. The new American Heart Association guidelines on the prevention of infective endocarditis: culmination of a long process of thought. Heart 2008;94:715-16.
13. Ashcroft R. Equipoise, knowledge and ethics in clinical research and practice. Bioethics 1999;13:314-26.
14. Lilford RJ. Equipoise is not synonymous with uncertainty. BMJ 2001;323:574.
15. Halpern SD. Evidence-based equipoise and research responsiveness. Am J Bioeth 2006;6:1-4.
16. Lilford RJ, Jackson J. Equipoise and the ethics of randomization. J R Soc Med 1995;88:552-9.
17. Gifford F. Freedman's 'clinical equipoise' and sliding-scale all-dimensions-considered equipoise'. J Med Philos 2000;25:399-426.
18. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-5.
19. Lilford RJ. Ethics of clinical trials from a Bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ 2003;326:980-1.
20. Alderson P. Equipoise as a means of managing uncertainty: personal, communal and proxy. J Med Ethics 1996;22:135-9.
21. Hellman D. Evidence, belief, and action: the failure of equipoise to resolve the ethical tension in the randomized clinical trial. J Law Med Ethics 2002;30:375-80.
22. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 2008;372:2152-61.
23. Agha Z, Lofgren RP, Van Ruiswyk JV. Is antibiotic prophylaxis for bacterial endocarditis cost-effective? Med Decis Making 2005;25:308-20.
24. Wray D, Brooks N, Gibbs J, et al. NICE Guideline on prophylaxis against infective endocarditis: guideline developer's response. BMJ e-letters 2008. http://www.bmj.com/cgi/eletters/336/7647/770#197065 (accessed 23 May 2010).
25. Mohindra RK. NICE, drug-eluting stents and the limits of trial data. Heart 2009;95:505-6.
26. National Institute for Health and Clinical Excellence. Social value judgements. principles for the development of NICE guidance. 2nd edn. Para 4.1. http://www.nice.org.uk/aboutnice/howwework/socialvaluejudgements/socialvaluejudgements.jsp (accessed 13 Feb 2010).
27. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224-7.
28. Mohindra R. Positing a difference between acts and omissions: the principle of justice, Rachels'cases and moral weakness. JME 2009;35:293-9.
29. National Institute for Clinical Excellence (Establishment and Constitution) Order 1999. SI 1990/220. http://www.opsi.gov.uk/si/si2005/20050497.htm.
30. Regulation 2 Directions and Consolidating Directions to the National Institute for Health and Clinical Excellence 2005 amended 2007. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsLegislation/DH_4109216 (accessed 16 May 2010).
31. Bogle RG, Ashrafian H. Antimicrobial prophylaxis for endocarditis: the authors reply. Heart 2007;93:753-54.
32. Pickersgill MD. NICE guidelines, clinical practice and antisocial personality disorder: the ethical implications of ontological uncertainty. J Med Ethics 2009;35:668-71.
33. Rawlins M, Dillon A. What's the evidence that NICE guidance has been implemented? More recent data on NICE implementation show different picture. BMJ 2005;330:1086.
34. Mohindra RK, Hall JA. Desmond's non-NICE choice: dilemmas from drug-eluting stents in the affordability gap. Clin Ethics 2006;192:105-8.
35. Associated Provincial Picture Houses Ltd v Wednesbury Corporation [1948] 1 KB 223
36. R v Bedwellty JJ ex. p. Williams [1977] AC 225.
37. R v Immigration Appeal Tribunal ex. p. Haile [2002] INLR 283.
38. Anismic Ltd v Foreign Compensation Commission [1969] 2 AC 147
39. Rothkin v Kent CC [1981] 1 WLR 1186
40. Dyson v Attorney General (1911-1912) [1911] 1 KB 410
41. Connaughton M. Commentary: controversies in NICE guidance on infective endocarditis. BMJ 2008;336:771.
42. Herring N, Sprigings DC. NICE on infective endocarditis: A call for national monitoring of antibiotic prophylaxis. BMJ 2008;336:976.